Filing Summary: Fresenius Medical Care AG & Co. KGaA
Business Context and Reporting Period
This Form 6-K, filed on August 3, 2010, reports the second quarter and half-year earnings results for the period ending June 30, 2010. The filing serves to distribute an Investor News release (Exhibit 99.1) containing the detailed financial performance of the Company.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached Investor News release (Exhibit 99.1). The Company utilizes non-GAAP financial measures, specifically EBITDA (operating income excluding interest, taxes, depreciation, and amortization) and free cash flow, to supplement GAAP results.
Material Changes and Comparisons
The filing text does not disclose specific material changes or comparative data versus prior periods. It notes that the non-GAAP measures are included to ensure consistency and comparability with prior periods where such measures were previously reported.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, or risk factors within the main text. It includes a standard disclaimer that the attached Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. The Company states that non-GAAP measures should not be used as a substitute for GAAP financial measures.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor News) for specific Q2 and H1 2010 revenue, net income, and EBITDA figures.
- Verify the reconciliation of non-GAAP measures (EBITDA and free cash flow) to GAAP measures as required by Regulation G.
- Confirm the specific details of the half-year earnings results not explicitly stated in this cover letter.
- Check for any forward-looking statements or updated guidance contained within the attached Investor News.